Pocket Pedia

WEIGHT AT BIRTH 3-12 MOS

KILOGRAMS 3.25 𝐴𝑔𝑒 𝑚𝑜𝑠 + 9 2 Age (yrs) X 2 + 8

1-6 YRS

POUNDS 7 Age (mos) + 11 Age ( yrs) X 5 + 17 Age ( yrs ) X 7 +5

7-12 YRS

𝐴𝑔𝑒 𝑦𝑟𝑠 𝑋 7 − 5 2

HEIGHT AT BIRTH AT I YR 2 -12 YR

centimeter 50 75 Age ( yr) X 6 +77

Inches 20 30 Age (yr) X 2.5 + 30 BODY SURFACE AREA : 𝐻𝑡 𝑐𝑚 𝑋𝑊𝑡 (𝑘𝑔) 3600

APGAR Sign Muscle tone (Acticity) Pulse Reflex irritability Grimace Color (Appearanc e) Respiration

2 active >100 Sneeze/cou gh All pink

Crying, rhythmic effective

1 Some flex./ext 100min

120 events/min ( 90 compressions /30 breaths)

Compression ventilation ration

5:1 ( pause for ventilation until trachea is intubated)

5:1 ( pause for ventilation until trachea is intubated)

3 :1

PENICILLINS Amoxicillin (Amoxil, Himox, Jamox)

30-50 mg/kg/day q 8 po

AmoxicillinClavulanic Acid or Coamoxiclav

30-50mg/kg/day q8 IV,PO

Ampicillin (Ampedia, Ampicin)

NB: 50-100 mkd q 6-8 IM/IV (up to 1 wk) 100-200mg/k/d q8 (1-4 wk) IN,CH: 100-200 mkd q 4-6 IM/IV

Syrup: 125mg/5ml, 250mg/ml cap:250mg, 500mg vial: 100,125,500mg/vi al

AmpicillinCloxacillin (pensyclox, Ampiclox,Cl oxamicin)

Ampi 250mg + cloxa 250 mg Same as ampicillin

250 mg cap 250mg/5ml syrup 75, 250, 500 mg vial

absent

NEWBORN RESUSCITATION ( Outside Delivery Room) 1. Warm, Position, Suction, Dry, tactile stimulation 2. Oxygen (Blow by) 3. Bag-Valve Mask Ventilation ( If heart rate < 100 Bmp or gasping respiration 4. Chest compression ( if heart rate < 60-80 bpm after ventilation intiated) 5. Medication – Epinephrine (if heart rate continues to fall or remains < 80 bpm)

Maneuver

Airway

Breathing Initial

Subsequent FBAQ

SUMMARY OF ABC MANEUVERS Child Infant 1 – 8 years 5 yrs: 30 mkd q 12 >5 yrs: 40 mkd q 12 A: 250mg q 12

Cefetamet

CH12 yrs: 500 mg po q 12

Cefoperazone

CH: 100-150mg/k/d q 6-8 IM/IV A: 2-12g/d IM/IV q 6-8 Cefotaxime IN,CH: 50-100mg/k/d q 12-16h A (gonorrhea): 500mg IM/IV SD Cefoxitin 80-160 mg/kg/day IM/IV q 4-8 3rd GENERATION Ceftriaxone 50-100mg/kg/day q12-24 (3rd gen) IV Typhoid:75-80mg/kg/day x A: 1-4 g/d

Ceftazidime (3rd gen)

Cefixime ( Tergecef Zefral, Ultraxime) Ceftizoxime (3rd gen) Cefotaxime Ceftazidime

NB3mos: 15mg/k/d q6 A: 1-2 g IV infusion *Crea clearnce of 15ml/min should not receive unless hemodialysis is instituted within 48 hrs 5-8 mg/k/d q 12

(dalacin-C) 150mg, 300mg cap 150mg/ml amp

Cotrimoxazole (SMX-TMP)

AMINOGLYCOSIDES Amikacin NB: 15 mkd q12 (1st (Amikin, wk) Pediakin) 15-22.5 mkd q8-12 (1-4 wks) IM/IV (over 12h) IN,CH,A: 15 mkd div q8 IM/IV (over 30-60 min) LD: 10 mg/k/dose Gentamicin NB: (Garamycin, 6 months 1 tsp TID

Terbutaline

Calcium Gluconate Dose: 200-300 Ex. WT x dose x prep 1.4 kg x 200 mg/ml = 290 mg/ml x 100mg /ml = 2.9 ml

Nebulizer 0.01 ml/kg (max of 1 ml in 3 ml NSS or 5-10 gtt in 2 ml NSS) q 6

Naloxone Dose: 0.1 mg/kg/dose IV/IM/SC Theophylline prep: 80 mg/ml 26.7 mg/ml dose: 2.5 mg/kg/dose q12

ANALGESICS Aspirin Thrombolytic RHD activity Kawasaki

Diclofenac

DOSE 65-130 mg/kg/d q 4-6 h 3-5 mg/k/day 75-100mg/k/day 80-100 mkd q 6h x 2wks then 3-5 mg/kg x 6-8 wks CH: 50 mg tab BID during or after meals A: 75-100 mg daily

Mefenamic Acid

6.5 mg/kg/dose q 6 h

Paracetamol

10-15 mg/kg/dose q 4-6 h

Ketotifen

Clenbuterol

PREPARATION 80 mg, 325 mg tab

25, 50 mg tab 100 mg tab (SR) 25mg/ml (3ml) amp 50 mg/5ml susp (ponstan, tynostan) 250, 500 mg tab/cap 150mg/ml (2ml amp) 125, 250 mg susp 325, 500 mg tab 120, 250/5ml syrup 60mg/0.6 ml drops

0.1-0.18-5 mkd po q 8 or 0.075 mg/k dose q 6 hr; or 1 mcg SC to rpt prn after 20 min once daily

6mos-3 yrs: 1 drop BID or 0.25 ml syr BID >3 yrs: 5 ml syrup BID Flat on bed for 4 hours >NPO temp for 2 hours then may feed once fully awake with aspiration precaution >Monitor VS q 15 min x 1 hour, q30 mins x 2 hours then q 1 till stable >Send CSF Specimen to the lab as ff: bottle #1 : GS/CS; AFB #2 : RBC, WBC, diff ct. #3 : protein/sugar #4 phadebact ( test for strep B, H. I influ, strep Pn, N meningitides)

Blood transfusion Orders

        

Secure and transfuse (blood product )to run for hours properly typed and x matched IVF to KVO while ongoing transfusion then Resume present IVF once transfusion is finished watch out for any untoward signs and symptoms such as fever, chills, rashes, DOB, tachycardia hook plain NSS while on BT to run at KVO monitor vs q 15 minutes while ongoing BT give paracetamol __ mg SIVP 1 hr prior to BT Inform PROD once blood product is available For repeat CBC 6 hours post BT (optional) Furosemide at 0.5- 1 mg/kg/dose mid

For BMA Orders            

prepare the ff Materials gloves size_____ eye sheet sterile cotton #1 sterile gauze # 2 glass slides #20 syringe 10 cc #2 5cc syringe #1 betadine #1 lidocaine 2% #2 70% alcohol secure consent pls. and post BT (depends sa AP)

For exchange transfusion orders Pls. prepare the following : French 5 feeding tube #2 3 way stopcock syringe connector sterile bottle 1L 10 cc syringe #2 betadine and alcohol sterile cotton sterile gauze #2 suture with needle note: give calcium gluconate 10% 0.7 ml + 0.7 ml sterile water IV push every 10 exchanges > give furosemide after exchange

Pulse Cyclophosphamide Therapy ( for Systemic Lupus Erythematosus) Pre hydration: - D5W 750 ml to run for 1 hour alternate with D5 0.3 Nacl 750 ml to run fo for 2 doses - Ondansetron (zafran) 8 mg/4ml, 4 mg +50 ml D5W to run for 30 mins - cyclphophamide 1gm (1000 mg) + 100 ml D5W to run for 1 hour Post chemo/ cyclophosphamide hydration - same regulation as pre chemo hydration - ondansetron 4mg + 50 ml D5W for 30mins - Prednisone 20 mg OD after breakfast - TPR q4 and record pls. - I and O q shift - limit sodium intake to 2 g/day - maintain on heplock after 10 hrs. therapy Materials for Triple Intrathecal (TIT) > NPO temp. For 4-6 hours > secure consent > prepare the ff. materials: - sterile gloves size_______ - sterile eyesheet - sterile cotton balls - sterile gauze - sterile water 50 ml #1 - tuberculin syringe #3 - sterile specimen bottle #1 - 2.5 cc syringe #1 >sterile needle g 23 or ___

2 mo–2 yr ACID PHOSPHATASE (Major sources: prostate and erythrocytes) Newborn 7.4–19.4 U/L 7.4–19.4 U/L 2–13 yr 6.4–15.2 U/L 6.4–15.2 U/L Adult male 0.5–11.0 U/L 0.5–11.0 U/L Adult female 0.2–9.5 U/L 0.2–9.5 U/L ALANINE AMINOTRANSFERASE (ALT) (Major sources: liver, skeletal muscle, and myocardium) Neonate/infant 13–45 13–45 U/L U/L Adult male 10–40 10–40 U/L U/L Adult female 7–35 U/L 7–35 U/L ALDOLASE (Major sources: skeletal muscle and myocardium) 10–24 mo 3.4–11.8 U/L 3.4–11.8 U/L 2–16 yr 1.2–8.8 U/L 1.2–8.8 U/L Adult 1.7–4.9 U/L 1.7–4.9 U/L ALKALINE PHOSPHATASE (Major sources: liver, bone, intestinal mucosa, placenta, and kidney) Infant 150–420 U/L 150–420 U/L 2–10 yr 100–320 U/L 100–320 U/L Adolescent males 100–390 U/L 100–390 U/L Adolescent 100–320 U/L 100–320 U/L females Adult 30–120 U/L 30–120 U/L

AMMONIA (Heparinized venous specimen on ice analyzed within 30 min) Newborn 90–150 μg/dL 64–107 μmol/L 0–2 wk 79–129 μg/dL 56–92 μmol/L >1 mo 29–70 μg/dL 21–50 μmol/L Adult 0–50 μg/dL 0–35.7 μmol/L AMYLASE (Major sources: pancreas, salivary glands, and ovaries) Newborn 5–65 U/L 5–65 U/L Adult 27–131 U/L 27–131 U/L ANTINUCLEAR ANTIBODY (ANA) Not significant 1 : significant 320 Patterns with clinical correlation: Centromere—CREST Nucleolar—Scleroderma Homogeneous—SLE ANTISTREPTOLYSIN O TITER (4-fold rise in paired serial specimens is significant) Preschool 19 7.35– 90–110 yr) 7.45

16–24 mmol/L 22–26 mmol/L

Paco2(mmHg)

HCO3−(mEq/L)

55

19

33

20

34

20

37

22

35–45

22–26

BILIRUBIN (TOTAL) Preterm Term Preterm Term Preterm Term Preterm Term Preterm Term Adult Neonate Infants/children CALCIUM (TOTAL) Preterm Full term